News - EAPM

last published

Global Trials, Local Relevance: A Scientific and Regulatory Framework for Regional Enrollment in Cancer Drug Development

Regional enrollment in cancer trials is moving rapidly up the policy agenda, with important consequences for regulation, health technology assessment, and patient access. A newly published review argues that global oncology development must do more to reflect population diversity and local standards of care if evidence is to remain credible

NEWS

Latest updates

Be informed and stay informed on all
news, events and publication updated.

SYNTHIA Survey on Synthetic Data in Healthcare

Focus on TOP 2026: Advancing Translational Oncology and Precision Medicine in Breast Cancer

EAPM Contributes to Strategic Alignment at JA PCM Kick-Off Meeting in Brussels

Bridging Science, Policy, and Practice for Equitable Innovation in Health [Newsletter]

EAPM in Berlin: Advancing Precision Oncology from Dialogue to Delivery

EAPM Participates in ON-COME Kick-Off in Rome: Advancing Holistic Care Pathways for Children with Cancer

From Policy to Practice: Driving Diagnostic Equity in HER2 Testing at the European Society of Pathology Congress

VISION Europe 2030

EVENTS

Let's get together

Be informed and stay informed on all
news, events and publication updated.

EAPM Contributes to Strategic Alignment at JA PCM Kick-Off Meeting in Brussels

The European Alliance for Personalised Medicine (EAPM) participated in the Kick-Off Meeting of the Joint Action on Personalised Cancer Medicine (JA PCM) in Brussels, as

EAPM in Berlin: Advancing Precision Oncology from Dialogue to Delivery

On 17–18 October 2025 in Berlin, the European Alliance for Personalised Medicine (EAPM) convened two key events aimed at accelerating the practical implementation of precision

EAPM Participates in ON-COME Kick-Off in Rome: Advancing Holistic Care Pathways for Children with Cancer

The European Alliance for Personalised Medicine (EAPM) was pleased to participate and present at the official kick-off meeting of the ON-COME project, held on 6–7

From Policy to Practice: Driving Diagnostic Equity in HER2 Testing at the European Society of Pathology Congress

The European Alliance for Personalised Medicine (EAPM) convened a high-level multi-stakeholder side event during the European Society of Pathology (ESP) Congress in Vienna, bringing together

VISION Europe 2030

2–3 September 2025, Club University Foundation in Brussels, visioneurope2030.com The European Alliance for Personalised Medicine (EAPM) is proud to host the upcoming VISION Europe 2030

Every Second Counts: Modernizing Cancer Screening to Save Lives

July 15, 2025 | 12:00–14:00 CET | European Parliament, Brussels Hosted by MEP Seán Kelly Cancer is on track to become the leading cause of

BEACON: Final Event

Milan, Italy, October 22-23, 2024

World Cancer Congress 2024: EAPM Side Event

Name: High-level Conference – Fighting Cancer around the World: A Framework for Action Location: Institute of Global Health; University of Geneva, Campus Biotech – G6;